A Phase I Pilot Study of Samarium-153 Combined With Neoadjuvant Hormonal Therapy and Radiation Therapy (IND# 65,173) in Men With Locally Advanced Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Samarium 153 lexidronam (Primary) ; Bicalutamide; Goserelin
- Indications Prostate cancer
- Focus Adverse reactions
- 02 Aug 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2010 Planned end date changed from 1 Mar 2008 to 1 Feb 2011 as reported by ClinicalTrials.gov.